Morgan Stanley analyst Jeffrey Hung maintains Rhythm Pharmaceuticals (NASDAQ:RYTM) with a Equal-Weight and raises the price target from $8 to $16.
Vital Energy Boosts Production & Profits In Permian Basin Through Strategic Buyout
Yesterday, Vital Energy, Inc. (NYSE: VTLE) disclosed the buyout of an additional working stake in producing assets related to the recent asset acquisition from Henry Energy LP, Moriah Henry Partners LLC, and Henry Resources LLC for
